WELL Sağlık Teknolojileri A.Ş. (TSE:WELL – Get Points) has been given a unanimous “Buy” recommendation by eight research firms currently covering the stock, MarketBeat.com reported. Six investment analysts rated the stock with buy recommendation. The average 1-year price target among analysts who graded the stock last year was C$8.25.
→ Free e-book: The Ultimate Guide to Investing in the Stock Market (from Vector Vest)
A number of brokerages have published reports on WELL. Scotiabank lowered its target price at WELL Health Technologies from C$7.50 to C$6.50 in a research note Thursday, November 3rd. CIBC lowered its target price for WELL Health Technologies from C$7.00 to C$6.50 and set a “better performance” rating for the company in a research note Friday (November 11th). Maxim Group reaffirmed its “buy” rating in a research note Friday, Oct. 14, and posted a target price of C$9.00 for WELL Health Technologies shares. Finally, TD Securities lowered its target price for WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” note for the company in a research note Friday (November 11th).
WELL Health Technologies Trade Increases 2.1%
Shares of WELL stock opened Monday at C$3.36. The stock’s fifty-day moving average is CAD 2.97 and its 200-day moving average is CAD 3.18. The company has a debt-equity ratio of 46.35, a quick ratio of 1.02 and a current ratio of 1.11. The firm has a market capitalization of CAD 766.64 million and a P/E ratio of -15.34. WELL Health Technologies has a fifty-two-week low of C$2.56 and a fifty-two-week high of C$5.64.
About WELL Health Technologies
(Get Rating)
WELL Health Technologies Corp. operates as a practitioner-driven digital health company in Canada, the United States and internationally. Provides end-to-end multi-channel patient services, including primary care; physiotherapy, occupational therapy, chiropractic, diet, mental health counseling and sleep-related services; special care, including gastroenterologists; diagnostic services related to cardiology, women’s health and bone/muscle health and cancer diagnosis; and telehealth services.
further reading
This instant news alert was created with narrative science technology and financial data from MarketBeat to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments regarding this story to [email protected]
You’ll want to hear this before considering WELL Health Technologies.
MarketBeat daily tracks Wall Street’s top-rated and best-performing research analysts and the stocks they recommend to their clients. MarketBeat identified five stocks top analysts whispered to their customers to buy right now before the wider market caught on… and WELL Health Technologies was not on the list.
WELL Health Technologies currently has a “Buy” rating among analysts, while top-rated analysts believe these five stocks are the better buys.
View Five Stocks Here
